Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...

The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...

The pipeline's workflow begins with the essential step of quality assessment. All incoming raw sequencing read files (typically in .fastq format) are first processed by FastQC. This tool generates ...

Study shows that rare variants captured by Illumina WGS with DRAGEN™ variant calling explain most of the "missing heritability" in complex human diseases and traits, including those related to blood ...

China is set to ease restrictions on some Illumina products, giving the sequencing giant a partial reprieve. Since March, Illumina has been barred from exporting its DNA sequencers to China, after ...

10x Genomics’ facility at 5500 Stoneridge Mall Road Pleasanton, CA, one of the company’s three sites in the San Francisco suburb. 10x Genomics has joined with two licensor partners to administer a ...

Oct 21 (Reuters) - Biotech company 10x Genomics (TXG.O), opens new tab filed two lawsuits against rival Illumina (ILMN.O), opens new tab in Delaware federal court on ...

This week, the Broad Institute gene-sequencing lab said it read infants’ DNA genomes in less than four hours, cutting an hour off the previous Guinness World Record. The point for investors is that ...

Taiwan-based gene sequencing company Genomics BioSci & Tech has entered a strategic partnership with global sequencing leader Illumina to jointly promote gene sequencing and multi-omics technologies ...

"Illumina has inflicted substantial harm on Element, resulting in lost sales, diminished market share, and reduced profits," counsel for DNA-sequencing company Element Biosciences Inc. alleged in an ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — A year ago, Illumina CEO Jacob Thaysen laid out a plan for the genomics ...